Disproquima talks Enzym acquisition: Expanding into Polish personal care

Disproquima has acquired Polish cosmetic ingredients distributor Enzym as part of its personal care expansion strategy. The raw materials and ingredients company says that the move represents a “significant milestone” in its Central European growth plan and will enable it to serve customers with greater proximity, technical know-how, and agility.

Enzym is said to be well established in the Polish market with its portfolio of cosmetics ingredient offerings and existing customer relationships. Disproquima states that Enzym’s formulation experience and customer network align with its long-term vision and business values.

The acquisition aims to strengthen Disproquima’s position in the fast-growing Central European market and deepens its expertise in offering sustainable, localized, and market-driven solutions.

The terms of the acquisition preserve internal knowledge by continuing the leadership of former co-owner Agnieszka Choynowska, who will take on the position of country manager for Poland. The company emphasizes that Choynowska’s regional knowledge and industry relationships will be an asset to Disproquima.

“Our shared philosophy and approach to client relationships make this a natural and promising integration,” says Choynowska. “With Disproquima’s global network and resources, we will be able to offer more value, innovation, and support to our partners across Poland.”

Personal Care Insights sits down with Sandra Sánchez, CEO at Disproquima, to discuss the company’s broader strategies, Disproquima’s compatibility with Enzym, and projected evolutions of the Polish personal care market.

How does this acquisition fit into Disproquima’s broader innovation strategy for the personal care segment?

Disproquima strengthens its presence in Poland.

Sánchez: This acquisition is fully aligned with Disproquima’s long-term strategy of strengthening our presence in key markets while enhancing our innovation capabilities in the personal care segment. By joining forces with Enzym, we are becoming closer to our customers in Central and Eastern Europe, allowing us to better understand local market trends and respond more quickly to evolving consumer demands.

One of the key added values Enzym brings is its dedicated Personal Care Applications Lab and highly experienced technical team. Together with our existing laboratories in Spain and Italy, this will create a stronger international network focused on developing inspiring formulations, market-driven concepts, and sustainable, clean-label solutions tailored to regional and global needs.

Ultimately, this acquisition reinforces our commitment to delivering high-performance ingredients supported by technical expertise and customer proximity.

What synergies do you foresee between Disproquima’s existing portfolio and Enzym’s product offerings, and how might this influence new product development?

Sánchez: Although both companies currently have complementary portfolios, we already see strong synergies emerging from this integration. One of the main opportunities will be introducing Disproquima’s ingredient portfolio into Enzym’s existing customer network, expanding access to raw materials and technologies across Central and Eastern Europe. Beyond the commercial synergies, we believe this collaboration will significantly strengthen our technical and formulation capabilities.

By combining market knowledge, application expertise, and local customer insights, we will be able to support Polish manufacturers more effectively in their product development processes and bring new concepts and solutions to market faster. This closer collaboration will help us offer more comprehensive, innovative, and customized solutions adapted to the evolving needs of the personal care industry.

How do you see the Polish personal care market evolving over the next few years, and what opportunities does this acquisition open up for Disproquima in the region?

Innovation lab drives new cosmetic formulations.

Sánchez: The Polish personal care market is one of the most dynamic and promising in Central Europe. Over recent years, it has shown consistent growth, driven by a strong manufacturing base, increasing consumer sophistication, and rising demand for sustainable products. With more than 1,500 personal care producers in the country, Poland represents a highly strategic market for our industry.

This acquisition gives Disproquima the opportunity to establish a much closer local presence and strengthen relationships with customers through technical support, formulation expertise, and local responsiveness. We see significant opportunities to introduce new ingredient technologies, sustainable concepts, and value-added solutions that can help Polish brands continue to innovate and remain competitive both locally and internationally.

Our goal is to become a trusted long-term partner for customers in the region by providing what we call “a World of Possibilities.”

How does Disproquima plan to leverage this acquisition to strengthen its competitive position across global markets?

Sánchez: This move represents an important milestone in Disproquima’s long-term international growth strategy. Our vision is to continue expanding our global footprint while maintaining the proximity, flexibility, and customer-centric approach that defines us as a company. Through this integration, we are strengthening our capabilities in Central and Eastern Europe by combining local expertise with Disproquima’s international network, technical knowledge, and global sourcing capabilities.

Our ambition is to provide customers worldwide with innovative solutions, high-quality ingredients, local stock availability, technical support, and the highest quality and regulatory standards. At the same time, this step reinforces our position as a growing international partner within the life science industry and lays the foundation for future expansion into additional strategic markets in the years ahead.